Study: AstraZeneca/Targacept drug fails depression test

posted by
November 8, 2011
The Raw Story    
Posted in PND News

"An experimental antidepressant from AstraZeneca Plc and Targacept Inc failed to meet the goal of changing a key depression rating score in the first of a series of pivotal clinical trials, in a setback for both firms. The result, announced by the companies on Tuesday, relates to the so-called Renaissance 3 Phase III study into TC-5214, a flexible dose trial conducted in Europe." (11/08/11)  

Our Sponsors